Advances in the understanding of allergic asthma

Allergy and Asthma Proceedings

Volumn 28, Issue 6, 2007, Pages 614-619

  Frieri, Marianne ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Airway remodeling; Allergic; Angiogenesis; Asthma; Biomarkers; Nitric oxide

Indexed keywords

ALLERGEN; AUTACOID; BUDESONIDE; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; NITRIC OXIDE; OMALIZUMAB; VASCULOTROPIN A;

ASTHMA; CONFERENCE PAPER; HUMAN; IMMUNOLOGY; METABOLISM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROLOGY; VIRUS INFECTION;

ALLERGENS; ANTIBODIES, MONOCLONAL; ASTHMA; BUDESONIDE; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; NITRIC OXIDE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38349116921     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2952     Document Type: Conference Paper

References (43)

1. Frieri M. Asthma concepts in the new millennium: Update in asthma pathophysiology. Allergy and Asthma Proc 26:83-88, 2005.
2. Bousquet J, Jeffery PK, Busse WW, et al. Asthma from broncho constriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720-1745, 2000.
3. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: New insights. J Allergy Clin Immunol 111:215-225, 2003.
4. Lemanske RF, and Busse WE. Asthma: Factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol 117:5456-5461, 2006.
5. Saglani S, Malmstrom K, Pelknon AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible air-flow obstruction. Am J Respir Crit Care Med 171:722-727, 2005.
6. Krawiec ME, Westcott JY, Chu HW, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 163:1338-1343, 2001.
7. Bisguard H, and Szelfler SJ. Understanding mild persistent asthma in children: The next frontier. J Allergy Clin Immunol 115:708-713, 2005.
8. Pascual RM, and Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol 116:477-486, 2005.
9. Lazaar AL, and Panettieri RA. Airway smooth muscle: A modulator of airway remodeling in asthma. J Allergy Clin Immunol 116:488-495, 2005.
10. Zimmermann J, Capetandes A, and Frieri M. MMP-9/TIMP-1 ratio in confluent human alveolar epithelial cells stimulating by D. pteronyssinus. J Allergy Clin Immunol 117:616a, 2006.
11. 112 mediator sensitization and inflammation in the lung. Nat Med 10:1095-1103, 2004.
12. Hoshino M, Takahashi M, and Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immuno-reactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295-301, 2001.
13. Capetandes A, Haque FN, and Frieri M. Confluent human pulmonary type II epithelial cells (A549) cells express cytoplasmic VEGF. J Invest Med 36:36.7, 2004 (Abs).
14. Capetandes A, Horne NS, and Frieri M. Dust-mite extract treated A549 cells and human lung mesenchimal growth. Ann Allergy Asthma Immunol 95:381-388, 2005.
15. Puxeddu I, Ribattti D, Crivellato E, et al. Mast cells and eosinophils: A novel links between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116:531-536, 2005.
16. Lemanski RT Jr. Viral infections and asthma. J Allergy Clin Immunol 114:1023-1026, 2004.
17. Seguerra E, Sirven V, and Frieri M. Bronchopulmonary dysplasia in premature infants. Possible predisposition to hyperreactive airway disease and asthma. Allergy Clin Immunol Int J World Allergy Org 18:5, 2006.
18. Frieri M. Airway epithelial cell release of cytokines. Immunodulation by various therapeutic agents. Allergy Asthma Proc 25: 387-393, 2004.
19. Gern JE, Brooks GD, Meyer P, et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 117:72-78, 2006.
20. Horne NS, Huang YC, and Frieri M. Modulation of IL-8 production and expression in respiratory virus stimulated human alveolar epithelial cells by budesonide and montelukast. J Allergy Clin Immunol 113:S192, 2004.
21. 2 agonists inhibit IL-8 secretion by RSV antigen-stimulated confluent human alveolar epithelial cells. J Allergy Clin Immunol 117:1227a, 2006.
22. Horne NS, Cappello V, Huang YC, and Frieri M. RANTES Production and Expression in Antigen and IL-1β Stimulates A549 Human Pulmonary Alveolar Epithelial Cells-Modulation by Budesonide. Presented at the Eastern Allergy Conference, Key Biscayne, FL, May 7, 2004.
23. -6M(RR) formoterol, but not (SS)-formoterol ar (S)(R)-albuterol inhibits RANTES secretion by RSV-antigen stimulated confluent human alveolar epithelial cells. J Allergy Clin Immunol 117:605a, 2006.
24. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic hyperresponsiveness as an additional guide to long-term treatment. The AMPUL study Group. Am J Respir Crit Care Med 159:1043-1051, 1999.
25. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts, a randomized controlled trial. Lancet 360:1715-1721, 2002.
26. Green RH, Brightling CE, Waltmann G, et al. Analysis of induced sputum in adults with asthma: Identification of a subgroup with isolated sputum neutrophils and poor response to inhaled corticosteroids. Thorax 57:875-879, 2002.
27. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Eng J Med 352:2163-2173, 2005.
28. Frieri M. Nitric oxide in allergic rhinitis and asthma. Allergy Asthma Proc 19:349-351, 1998.
29. American Thoracic Society and European Respiratory Society: Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171: 912-938, 2005.
30. Erzurum SC. Nitric oxide in asthmatic inflammation session 5815. Workshop presented at the American Academy of Allergy Asthma Immunology Meeting, March 7, 2006.
31. Casale TB. Status of immunotherapy current and future. J Allergy Clin Immunol 113:1036-1039, 2004.
32. Holgate S, Casale T, Wenzel S, et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 115:459-65, 2005.
33. Corry DB, and Kheradmand F. Control of allergic airway inflammation through immuno modulaton. J Allergy Clin Immunol 117:5461-5464, 2006.
34. Djukanovic R, Wilson SJ, Kraft M, et al. Effects of treatment with anti-immunoglobulin E antibody E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 1120:583-593, 2004.
35. Huang YC, Leyko BT, and Frieri M. Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells. Ann Allergy Asthma Immunol 95:443-451, 2005.
36. Stokes J, and Casale TB. Rationale for new treatments aimed at IgE immunomodulation. Ann Allergy Asthma Immunol 93:212, 217, 2004.
37. Yoshida M, Aizawa H, Inoune H, et al. Effect of suplatast tosilatic on airway hyperresponsiveness and inflammation. J Asthma 39:545-552, 2002.
38. Panettieri R. Airway smooth muscle immunomodulatory cells. Allergy Asthma Proc 25:381-386, 2004.
39. Gern JE. Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immunol. 105(Suppl 2): S497-S502, 2000.
40. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 172:149-160, 2005.
41. Frieri, M. Update in Allergy Immunology. Nassau University Medical Center, East Meadow, NY, 2005.
42. Capetandes A, Zimmermann J, and Frieri M. Adhesion of human lung microvascular endothelial cells (HLMVEC) is decreased by conditioned media from D. pteronyssinus-treated confluent human type II alveolar epithelial cells containing elevated TGFB1. J Allergy Clin Immunol 115:514, 2005.
43. Holtzman MJ, Morton JD, Shornick LP, et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: Epithelial-viral-allergic paradigm. Physiol Rev 82:19-46, 2002.